DK0060448595
DK0060448595
Coloplast B A/S
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 65/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).
Beta (Market Relation)
0.57x
DefensiveVolatility (5Y p.a.)
26.8% p.a.
5-Year HorizonMax Drawdown (5Y)
-68.5%
5-Year HorizonSharpe Ratio
-0.67
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -26.9% |
| 3 Years | 25.4% | -61.9% | -0.75 | -16.6% |
| 5 Years | 26.8% | -68.5% | -0.67 | -15.6% |
| 10 Years | 25.1% | -68.5% | -0.16 | -1.4% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.5% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
1 ISS Score: 1 / 10
Audit Risk
1 ISS Score: 1 / 10
Board Risk
1 ISS Score: 1 / 10
Short Ratio
-